Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

114 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Completed

Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera

NCT01243073

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • MDACC - Orlando Orlando, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University - Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States
View Trial Details
Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

NCT00586651

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • NY Presbyterian-Cornell New York, United States
  • Mount Sinai School of Medicine New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details
Completed

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00357305

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +78 more
Locations
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions